Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites

Details for Australian Patent Application No. 2010319559 (hide)

Owner Allegro Pharmaceuticals, Inc.

Inventors Mackel, Michael John; Park, John

Agent Davies Collison Cave

Pub. Number AU-A-2010319559

PCT Pub. Number WO2011/060104

Priority 61/259,748 10.11.09 US

Filing date 10 November 2010

Wipo publication date 19 May 2011

International Classifications

A61K 51/06 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/060104 Priority application(s): WO2011/060104

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010319581-Spiropiperidine compounds as ORL-1 receptor antagonists

2010319555-Method for generation and regulation of iPS cells and compositions thereof